GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (OTCPK:SHTDF) » Definitions » Cyclically Adjusted Price-to-FCF

Sinopharm Group Co (Sinopharm Group Co) Cyclically Adjusted Price-to-FCF : 5.87 (As of May. 01, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Cyclically Adjusted Price-to-FCF?

As of today (2024-05-01), Sinopharm Group Co's current share price is $2.64. Sinopharm Group Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was $0.45. Sinopharm Group Co's Cyclically Adjusted Price-to-FCF for today is 5.87.

The historical rank and industry rank for Sinopharm Group Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHTDF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 5.4   Med: 7.05   Max: 8.23
Current: 5.4

During the past 13 years, Sinopharm Group Co's highest Cyclically Adjusted Price-to-FCF was 8.23. The lowest was 5.40. And the median was 7.05.

SHTDF's Cyclically Adjusted Price-to-FCF is ranked better than
93.75% of 32 companies
in the Medical Distribution industry
Industry Median: 25.865 vs SHTDF: 5.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sinopharm Group Co's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was $0.666. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.45 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sinopharm Group Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sinopharm Group Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Cyclically Adjusted Price-to-FCF Chart

Sinopharm Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.46 7.59 6.05 5.89 5.59

Sinopharm Group Co Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.89 - - 5.59 -

Competitive Comparison of Sinopharm Group Co's Cyclically Adjusted Price-to-FCF

For the Medical Distribution subindustry, Sinopharm Group Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Group Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's Cyclically Adjusted Price-to-FCF falls into.



Sinopharm Group Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sinopharm Group Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=2.64/0.45
=5.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopharm Group Co's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Sinopharm Group Co's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.666/114.6694*114.6694
=0.666

Current CPI (Dec23) = 114.6694.

Sinopharm Group Co Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.230 99.000 0.266
201512 0.679 100.600 0.774
201612 0.412 102.600 0.460
201712 0.048 104.500 0.053
201812 0.012 106.500 0.013
201912 0.779 111.200 0.803
202012 0.446 111.500 0.459
202112 0.356 113.108 0.361
202212 0.852 115.116 0.849
202312 0.666 114.669 0.666

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sinopharm Group Co  (OTCPK:SHTDF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sinopharm Group Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Group Co (Sinopharm Group Co) Business Description

Traded in Other Exchanges
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Sinopharm Group Co (Sinopharm Group Co) Headlines

From GuruFocus

Matthews China Fund Comments on Sinopharm Group

By Vera Yuan Vera Yuan 10-20-2014

Matthews China Fund Comments on Sinopharm

By Holly LaFon Holly LaFon 05-19-2016

Matthews China Fund 1st Quarter Commentary

By Holly LaFon Holly LaFon 05-19-2016

Matthews China Fund Comments on Sinopharm

By Sydnee Gatewood Sydnee Gatewood 01-25-2021

Matthews China Fund Comments on Sinopharm

By Sydnee Gatewood Sydnee Gatewood 07-30-2020

Matthews China Fund Q3 2014 Commentary

By Holly LaFon Holly LaFon 10-18-2014